Back Dictionary Export CSV
Filter: Clear
ENCORE_PATIENT_ID MERGED_REGIMEN_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION BENCHMARK_GROUP LINK_NUMBER
20139972 20175753 null null Palliative (P) null 2021-04-20 ECF 02 Y CARBOPLATIN + PEMBROLIZUMAB + PEMETREXED 101249641
20141651 20175754 1.71 78.15 Curative (C) 2017-06-09 2017-06-09 ECarboX 02 N CYCLOPHOSPHAMIDE + RITUXIMAB 100425644
20141745 20175755 1.8 65.4 Palliative (P) 2019-12-11 2019-12-17 DARATUMUMAB 02 null STS RHABDOMYOSARCOMA RMS 2005 IVA 101465889
20142578 20175756 1.53 50.5 null 2017-11-15 2019-04-14 GEFITINIB 02 null BEVACIZUMAB + FLUOROURACIL + IRINOTECAN 100943522
20142915 20175757 null null null 2021-06-01 2022-02-19 COSMIC TRIAL 02 N CYCLOPHOSPHAMIDE + DOXORUBICIN + VINCRISTINE 100097838
20143244 20175758 1.81 61.8 Curative (C) 2019-05-31 2019-06-21 IRINOTECAN + MDG + PANITUMUMAB 02 N CAPECITABINE + OXALIPLATIN + TRASTUZUMAB 100190619
20143370 20175759 null 74.15 null 2017-01-27 2017-01-29 INTERAACT trial 02 N CAPECITABINE + CISPLATIN + STREPTOZOCIN 100028118
20143492 20175760 1.56 59.8 Palliative (P) 2020-07-28 2020-08-09 OXALIPLATIN + MDG + PANITUMUMAB 02 N ECARBOX 100834785
20143702 20175761 1.46 79 Curative (C) 2017-11-28 2018-03-18 ACTICCA-1 Trial 02 null DARATUMUMAB 100482860
20143988 20175762 1.56 0 null 2019-10-29 2019-11-03 EPIRUBICIN + FLUOROURACIL + OXALIPLATIN 02 null SCOPE2 TRIAL 101187221
20144687 20175763 1.77 53.9 Palliative (P) 2018-02-15 2018-03-08 Etoposide IV 02 null EPIRUBICIN 100262936
20144867 20175764 1.79 66.2 03 2019-11-09 2019-11-12 LORLATINIB 02 N CAPECITABINE + DOCETAXEL 100413733
20147170 20175765 1.65 null Palliative (P) 2020-04-10 2020-04-23 Ifosfamide 02 N IBRUTINIB 101789225
20147403 20175766 1.81 70 Palliative (P) 2019-07-07 2019-09-02 EC 02 N GEMCITABINE + OXALIPLATIN 100772465
20148182 20175768 0 78.3 Palliative (P) 2018-02-20 2019-03-21 PHITT D Carboplatin / doxorubicin . 02 N TEMOZOLOMIDE 101627462
20148558 20175769 1.81 93.8 Curative (C) 2020-08-06 2020-08-08 ECarboF 02 N DARATUMUMAB 101213518
20149423 20175771 1.77 85.9 03 2021-08-11 2021-08-24 Bevacizumab + Irinotecan + MdG 02 N OXALIPLATIN + MDG + PANITUMUMAB 101183253
20150859 20175772 1.77 11.9 Palliative (P) 2017-09-06 2021-08-14 BORTEZOMIB + THALIDOMIDE 02 N CARBOPLATIN + VINORELBINE 101533733
20151823 20175773 1.75 56.5 Curative (C) 2022-04-25 2022-05-03 GO2 TRIAL 02 N NAB-PACLITAXEL 100679599
20152042 20175774 1.77 81.2 null 2018-09-22 2018-10-12 COSMIC TRIAL 02 N TEMOZOLOMIDE 100555245
20152086 20175775 1.83 77 Palliative (P) 2021-09-03 2021-09-03 Carboplatin + Vinorelbine Oral 02 null RITUXIMAB 100729830
20153102 20175776 1.74 68 null 2018-03-29 2018-03-29 Docetaxel + Nintedanib 02 N MELPHALAN 100467017
20153571 20175777 null null Curative (C) 2022-02-25 2022-03-11 Capecitabine + Streptozocin 02 N FOCUS4 TRIAL 101299683
20153599 20175778 1.55 87.4 Palliative (P) 2016-10-03 2016-10-12 ARISTOTLE TRIAL 02 null CISPLATIN + FLUOROURACIL + TRASTUZUMAB 101454725
20154024 20175779 1.75 83.8 Palliative (P) 2020-02-13 2020-04-09 POMALIDOMIDE 02 N CAPECITABINE + STREPTOZOCIN 101388079
20154786 20175782 1.81 53.4 Adjuvant (A) 2019-04-10 2019-05-25 Hepatoblastoma SR Cisplatin 02 N RUCAPARIB 100122535
20155475 20175783 1.56 80.8 Curative (C) 2021-04-18 2021-07-04 Pertuzumab (Loading) 02 N EPIRUBICIN + FLUOROURACIL + OXALIPLATIN 101204404
20155759 20175785 1.65 66.2 Palliative (P) 2020-02-22 2020-04-16 SCOPE 2 TRIAL 02 N IRINOTECAN + RALTITREXED 101793421
20157177 20175788 1.79 67 Palliative (P) 2021-11-09 2021-12-05 SCOPE 2 TRIAL 02 N CISPLATIN + DOCETAXEL 101243634
20157247 20175789 1.75 62.6 Palliative (P) 2021-04-08 2021-06-01 Cisplatin + Radiotherapy + CISPLATIN 02 N CYCLOPHOSPHAMIDE + LENALIDOMIDE 101484743
20158965 20175791 1.52 47 Palliative (P) 2018-09-03 2018-09-09 Hydroxycarbamide 02 N DARATUMUMAB 101443493
20159094 20175792 1.57 70 Palliative (P) 2020-09-08 2020-09-24 CARBOPLATIN + CETUXIMAB + FU 02 N MITOMYCIN 101121232
20159217 20175793 1.71 37.9 Palliative (P) 2022-01-15 2022-02-14 CAPECITABINE + MITOMYCIN + RT 02 N CARBOPLATIN + PEMBROLIZUMAB + PEMETREXED 100609557
20159318 20175794 1.51 109.4 null 2017-01-17 2017-02-10 Carboplatin + Liposomal Doxorubicin 02 N COSMIC TRIAL 101398261
20159362 20175795 1.75 93.9 Palliative (P) 2021-01-16 2021-02-05 Etoposide + Ifosfamide (5 days) 02 null IBRUTINIB 101603763
20159370 20175796 1.87 67.4 null 2020-12-11 2021-01-16 ECF 02 null RITUXIMAB 101429125
20161556 20175798 1.71 0 null 2018-03-31 2018-04-09 AFATINIB 02 null HYDROXYCARBAMIDE 101182578
20163011 20175800 1.75 79.2 Adjuvant (A) 2019-02-24 2019-08-22 DARATUMUMAB 02 N EPIRUBICIN + FLUOROURACIL + OXALIPLATIN 100465565
20164336 20175801 1.69 80.9 null 2018-09-09 2018-11-12 AML17 TRIAL 02 N ETOPOSIDE 101712263
20164782 20175802 1.92 95 Palliative (P) 2020-04-29 2020-05-10 CT7001 2 null BALLAD TRIAL 100187380
20167598 20175803 1.82 66.85 null 2022-01-12 2022-03-02 null 02 N IPILIMUMAB + NIVOLUMAB 100419704
20168615 20175804 1.84 87 null 2017-09-17 2017-09-17 INTERAACT trial 02 null CAPECITABINE + STREPTOZOCIN 101279647
20169180 20175806 null null Palliative (P) 2016-05-08 2018-01-28 Azacitidine 02 N CAPECITABINE + OXALIPLATIN + TRASTUZUMAB 100813839
20171355 20175808 1.58 45.9 Palliative (P) 2018-05-31 2018-06-01 HEP HR Hepatoblastoma gde carbo dox 02 N CISPLATIN + FLUOROURACIL + RT 100547999
20171611 20175809 1.77 67 Palliative (P) 2017-10-01 2017-10-28 FCarboSt 02 Y ESPAC TRIAL 100691231
20171685 20175810 1.84 55.8 Palliative (P) 2022-03-26 2022-04-02 Cape+Cetuximab+Oxalip (2 wk) Maint 02 N CISPLATIN + FLUOROURACIL + TRASTUZUMAB 100753451
20172887 20175812 1.82 97 Palliative (P) 2021-10-02 2021-10-22 CAV 02 null CAPECITABINE + CETUXIMAB + OXALIPLATIN 101667430
20173337 20175813 null 94 null 2018-12-09 2018-12-14 Pemetrexed 02 N TACE-3 TRIAL 100025739
20175290 20175814 1.6 80.5 Curative (C) 2019-07-15 2019-07-24 Cisplatin + Fluorouracil + Streptozocin 02 N IPILIMUMAB + NIVOLUMAB 101297314
20177203 20175816 1.6 105 null 2020-09-27 2020-10-11 Venetoclax 02 null CISPLATIN + PEMETREXED 100570393